Altered BDNF signaling has been implicated in several neurodegenerative diseases, including Huntington's, Alzheimer's and Parkinson's diseases [9] and relevant therapeutic strategies for these disorders are aimed at increasing BDNF levels in the brain [10], [11]. Here, BDNF is linked to Parkinson disease.